|
|
 | | | |
- close
- close
- close
- close
Ligand Pharmaceuticals (LGND) |
StreetInsider.com
May 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharmaceuticals+%28LGND%29+Agreement+with+Merck+KGaA+Unit+Terminated/8352871.html for the full story.
Benzinga
May 14
Comment
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that its partner Rib-X Pharmaceuticals, Inc. has initiated a Phase 3 clinical trial of a Captisol-enabled™ intravenous (IV) formulation of delafloxacin for the first-line...
Benzinga
May 8
Comment
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the first quarter ended March 31, 2013, and provided an operating forecast and program updates.
“We have had an excellent start to 2013 and are excited...
Benzinga
Apr 22
Comment
Ligand Pharmaceuticals (NASDAQ: LGND) shares touched a new 52-week high of $27.71. Ligand is expected to report its Q1 results on May 8th.
Dish Network (NASDAQ: DISH) shares gained 1.97% to reach a new 52-week high of $39.77. Sprint Nextel's...
FierceBiotech
Mar 27
Comment
Cambridge, MA-based Acceleron has snagged two orphan indications for ACE-536, an experimental therapy for two rare blood disorders: beta-thalassemia and myelodysplastic syndromes. Acceleron launched its mid-stage study of 536 for beta-thalassemia...
Benzinga
Mar 18
Comment
In a report published Monday, Cantor Fitzgerald analyst Irina Rivkind reiterated a Hold rating on Ligand Pharmaceuticals (NASDAQ: LGND), and raised the price target from $23.00 to $26.00.
In the report, Rivkind noted, “On March 14 the company...
Benzinga
Mar 14
Comment
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the
signing of global license and supply agreements with Spectrum
Pharmaceuticals, Inc. (NASDAQ: SPPI) for the development and
commercialization of Ligand's...
Benzinga
Dec 13
Comment
Pfizer Inc. (NYSE: PFE) and Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
today announced that the United States Food and Drug Administration (FDA)
accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated
estrogens...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
